Virica is pleased to announce it is part of the Canadian Pandemic Preparedness Hub (CP2H), a new research hub designed to protect Canadians against future pandemics and emerging threats.

This multidisciplinary hub is part of an investment by the Government of Canada to grow a strong and competitive biomanufacturing and life sciences sector.

“To continue to protect Canadians and to build a resilient biomanufacturing ecosystem, our government is taking every action possible to be equipped with the best tools. We’re proud to foster the research needed to produce cutting-edge discoveries and products in our very own labs that will help us build a stronger, more robust life sciences sector that responds to the needs of Canadians for decades to come,” said the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, in a PRESS RELEASE.

“We look forward to using our yield-enhancing technology to accelerate the manufacturing of made-in-Canada medicines, in a cost-effective and timely fashion,” said Ella Korets-Smith, Chief Strategy Officer, Virica Biotech.

To bridge the gap between lab and market, CP2H brings together more than 45 strategic partners from academia, industry, non-profit and governmental agencies from across Canada.

Breakthrough technology is both intimidating and exhilarating

To achieve the promise of viral medicine, though, the innovation of many is needed. We’re here to guide the way. Let our scientific experience and expertise support you, your science and your business. Let’s talk.

Have a question? Contact Virica